LongTXGSep 2026
10x Genomics, Inc.
10x Genomics supplies leading single-cell and spatial-analysis platforms for life sciences research. Results beat expectations, and management raised full-year guidance following…
TXG
1 published idea on 10x Genomics, Inc. across 1 fund — 1 long and 0 short.
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on 10x Genomics: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
10x Genomics supplies leading single-cell and spatial-analysis platforms for life sciences research. Results beat expectations, and management raised full-year guidance following…